SEARCH

SEARCH BY CITATION

References

  • AIDS Alert International (2005) UNAIDS report focuses on Asia and cites growing epidemic in the East, particularly China, Indonesia, Vietnam. AIDS Alert, NA. 8-1-2005.
  • Akbar N, Basuki B, Mulyanto et al. (1997) Ethnicity, socioeconomic status, transfusions and risk of hepatitis B and hepatitis C infection. Journal of Gastroenterology and Hepatology 12, 752757.
  • Allwright S, Bradley F, Long J et al. (2000) Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in Irish prisoners: results of a national cross sectional survey. BMJ 321, 7882.
  • Altice FL, Marinovich A, Khoshnood K et al. (2005) Correlates of HIV infection among incarcerated women: implications for improving detection of HIV infection. Journal of Urban Health 82, 312326.
  • Baillargeon J, Giordano TP, Rich JD et al. (2009) Accessing antiretroviral therapy following release from prison. JAMA 301, 848857.
  • Behrendt C, Kendig N, Dambita C et al. (1994) Voluntary testing for human immunodeficiency virus (HIV) in a prison population with a high prevalence of HIV. American Journal of Epidemiology 139, 918926.
  • Butler T, Boonwaat L, Hailstone S et al. (2007) The 2004 Australian prison entrants’ blood-borne virus and risk behaviour survey. Australian and New Zealand Journal of Public Health 31, 4450.
  • Celentano DD, Galai N, Sethi AK et al. (2001) Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users. AIDS 15, 17071715.
  • Derlega VJ, Winstead BA & Brockington JE Jr (2008) AIDS stigma among inmates and staff in a USA state prison. International Journal of STD and AIDS 19, 259263.
  • Direktorat Jendral Pemasyarakatan (2007) Petunjuk pelaksanaan & petunjuk tenis layanan perawatan, dukungan dan pengobatan HIV dan AIDS di Lapas/Rutan.
  • Dolan K, Kite B, Black E, Aceijas C & Stimson GV (2007) HIV in prison in low-income and middle-income countries. Lancet Infectious Diseases 7, 3241.
  • Ferreira RC, Rodrigues FP, Teles SA et al. (2009) Prevalence of hepatitis B virus and risk factors in Brazilian non-injecting drug users. Journal of Medical Virology 81, 602609.
  • French AL, Lin MY, Evans CT et al. (2009) Long-term serologic follow-up of isolated hepatitis B core antibody in HIV-infected and HIV-uninfected women. Clinical Infectious Diseases 49, 148154.
  • Freudenberg N (2001) Jails, prisons, and the health of urban populations: a review of the impact of the correctional system on community health. Journal of Urban Health 78, 214235.
  • Mathers BM, Degenhardt L, Phillips B et al. (2008) Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet 372, 17331745.
  • Mesquita F, Winarso I, Atmosukarto II et al. (2007) Public health the leading force of the Indonesian response to the HIV/AIDS crisis among people who inject drugs. Harm Reduction Journal 4, 9.
  • Ministry of Health of Indonesia (2007) Report on HIV/AIDS, Jakarta.
  • Ministry of Health of Indonesia (2008) Mathematic model of HIV epidemic in Indonesia 2008–2014. 12-1-2008.
  • Morrison DS & Gilchrist G (2001) Prison admission health screening as a measure of health needs. Health Bulletin 59, 114119.
  • Nelwan EJ, Diana A, Van Crevel R et al. (2009) Indonesian prisons and HIV: part of the problem, part of the solution? Acta Medica Indonesiana 41(Suppl. 1), S52S56.
  • Pisani E, Garnett GP, Grassly NC et al. (2003) Back to basics in HIV prevention: focus on exposure. BMJ 326, 13841387.
  • Samuel MC, Doherty PM, Bulterys M & Jenison SA (2001) Association between heroin use, needle sharing and tattoos received in prison with hepatitis B and C positivity among street-recruited injecting drug users in New Mexico, USA. Epidemiology and Infection 127, 475484.
  • Solomon SS, Celentano DD, Srikrishnan AK et al. (2009) Mortality among injection drug users in Chennai, India (2005–2008). AIDS 23, 9971004.
  • Spaulding A, Stephenson B, Macalino G et al. (2002) Human immunodeficiency virus in correctional facilities: a review. Clinical Infectious Diseases 35, 305312.
  • Springer SA, Friedland GH, Doros G, Pesanti E & Altice FL (2007) Antiretroviral treatment regimen outcomes among HIV-infected prisoners. HIV Clinical Trials 8, 205212.
  • Stark K, Muller R, Bienzle U & Guggenmoos-Holzmann I (1996) Frontloading: a risk factor for HIV and hepatitis C virus infection among injecting drug users in Berlin. AIDS 10, 311317.
  • Sulaiman HA, Julitasari, Sie A et al. (1995) Prevalence of hepatitis B and C viruses in healthy Indonesian blood donors. Transactions of the Royal Society of Tropical Medicine and Hygiene 89, 167170.
  • Thaisri H, Lerwitworapong J, Vongsheree S et al. (2003) HIV infection and risk factors among Bangkok prisoners, Thailand: a prospective cohort study. BMC Infectious Diseases 3, 25.
  • Weinbaum CM, Sabin KM & Santibanez SS (2005) Hepatitis B, hepatitis C, and HIV in correctional populations: a review of epidemiology and prevention. AIDS 19(Suppl 3), S41S46.
  • Wilson D, Ford N, Ngammee V, Chua A & Kyaw MK (2007) HIV prevention, care, and treatment in two prisons in Thailand. PLoS Medicine 4, e204.
  • Zaller N, Thurmond P & Rich JD (2007) Limited spending: an analysis of correctional expenditures on antiretrovirals for HIV-infected prisoners. Public Health Reports 122, 4954.